Publication | Closed Access

Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention

ThrombopoiesisThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseBlood PlateletAtherosclerosisHematologyPharmacologyCut-off LevelsPharmacotherapyOn-clopidogrel Platelet AggregationPlatelet AntagonistMedicineAnticoagulantCardiologyCoronary Artery Disease